ONCORLIA
DEAD

Serial Number

87077399

Owner

Array BioPharma Inc.

Attorney

Cynthia Johnson Walden

Filing Date

Jun 20, 2016

Add to watchlist:

No watchlists yet
View on USPTO

ONCORLIA Trademark

Serial Number: 87077399

ONCORLIA is a trademark filed by Array BioPharma Inc. on June 20, 2016. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Array BioPharma Inc. (29 trademarks)

Boulder, CO 80301

Entity Type: 03

Trademark Details

Filing Date

June 20, 2016

Registration Date

Not Registered

Published for Opposition

October 25, 2016

Goods & Services

Anti-infectives; Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer and tumors; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Jul 24, 2017 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jul 24, 2017 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 20, 2016 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 25, 2016 NPUB
PUBLISHED FOR OPPOSITION
Oct 25, 2016 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 5, 2016 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 15, 2016 CNSA
ASSIGNED TO EXAMINER
Sep 15, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 24, 2016 NWOS
NEW APPLICATION ENTERED
Jun 23, 2016 NWAP